ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback